News

Preliminary results from 22 patients were reported in an ongoing Phase I clinical trial evaluating the safety and preliminary efficacy of TH-302 in patients with advanced solid tumors.

Discovered and developed by Astellas, Vaprisol, an arginine vasopressin receptor antagonist, is said to be the first and only approved drug indicated for the treatment of both euvolemic

The dispute between the competitors lasted for more than three years, with each party asserting that the other’s cold sore remedy advertising claims constituted false advertising in violation

The company anticipates the reporting of final results and statistical analysis for the study within the next two to three weeks. The new study concerns assessment of the

Advitech and PL Thomas (PLT) have concluded a non-exclusive distribution agreement with a yearly commitment for Advitech’s XP-828L ingredient, a patent-pending composition consisting of growth factors, especially TGF-

InterStim therapy is a reversible treatment for patients with fecal incontinence after conservative treatments have failed. Once approved by the FDA, InterStim therapy for fecal incontinence will be

The investment, led by Inventages, will advance continued development of the Neuroptix Sapphire diagnostic platform and related technologies. The Neuroptix Sapphire system consists of a non-contact optical device

Dr Khvorova has previously served as chief scientific officer at Dharmacon, a developer and supplier of RNAi compounds. Prior to Dharmacon, Dr Khvorova served as research scientist with

Olmesartan medoxomil hydrochlorothiazide tablets, indicated for the treatment of high blood pressure, are the generic version of Daiichi Sankyo’s Benicar HCT. Mylan Pharmaceuticals has previously submitted its original